Specialist-Led Model of Care Can Improve CVD Prevention in Psoriasis
Dermatologists and patients with psoriatic disease approve of a specialist-led model of care, HealthDay reports.
Dermatologists and patients with psoriatic disease approve of a specialist-led model of care, HealthDay reports.
A late-breaking presentation at AAD 2025 highlights the efficacy and safety of an oral TYK2 inhibitor, showing significant skin clearance in moderate-to-severe psoriasis patients.